Blood cancers, Chronic leukaemia, Chronic lymphocytic leukaemia (CLL), Leukaemia
Results
Phase 2
This study was for people with chronic lymphocytic leukaemia (CLL) that had come back after treatment, or treatment had stopped working.
It was open for people to join between 2016 and 2017, and the team published the results in 2019.
Recruitment start: 20 May 2016
Recruitment end: 30 November 2017
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Peter Hillmen
University of Birmingham
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Janssen-Cilag
Abbvie
Blood Cancer UK
Last reviewed: 22 February 2021
CRUK internal database number: 13896
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
